Back to top
more

Mesa Laboratories, Inc. (MLAB)

(Delayed Data from NSDQ)

$130.92 USD

130.92
5,763

+0.21 (0.16%)

Updated Aug 23, 2017 03:59 PM ET

Add to portfolio

5-Strong Sell         5

F Value | B Growth | F Momentum | D VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for MLAB

 

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Mesa Laboratories, Inc. falls in the month of March.

All items in Millions except Per Share data.

3/31/2017 3/31/2016 3/31/2015 3/31/2014 3/31/2013
Assets          
Cash & Equivalents 6 6 2 6 4
Receivables 14 15 12 9 8
Notes Receivable 0 0 0 0 0
Inventories 14 14 12 8 6
Other Current Assets 2 2 3 4 1
Total Current Assets 36 37 30 27 19
Net Property & Equipment 26 17 10 8 7
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 110 107 78 63 39
Deposits & Other Assets 0 0 0 0 0
Total Assets 172 161 117 98 66
Liabilities & Shareholders Equity 3/31/2017 3/31/2016 3/31/2015 3/31/2014 3/31/2013
Notes Payable 0 0 0 0 0
Accounts Payable 2 3 3 2 1
Current Portion Long-Term Debt 1 3 3 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 7 8 5 6 3
Income Taxes Payable 1 2 1 0 1
Other Current Liabilities 5 8 3 2 0
Total Current Liabilities 17 24 15 10 5
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4 5 5 5 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 54 42 23 17 4
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 4 1 2 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 74 76 44 33 13
Shareholders Equity 3/31/2017 3/31/2016 3/31/2015 3/31/2014 3/31/2013
Preferred Stock 0 0 0 0 0
Common Stock (Par) 26 21 18 16 11
Capital Surplus 0 0 0 0 0
Retained Earnings 74 65 56 49 42
Other Equity -2 -1 -0 0 -0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 98 85 73 64 53
Total Liabilities & Shareholder's Equity 172 161 117 98 66
Total Common Equity 98 85 73 64 53
Shares Outstanding 3.70 3.60 3.50 3.40 3.30
Book Value Per Share 26.44 23.52 20.99 18.92 15.98

Fiscal Year End for Mesa Laboratories, Inc. falls in the month of March.

All items in Millions except Per Share data.

6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016
Assets          
Cash & Equivalents 3 6 5 5 5
Receivables 13 14 13 13 12
Notes Receivable 0 0 0 0 0
Inventories 13 14 15 14 14
Other Current Assets 5 2 2 1 1
Total Current Assets 34 36 35 34 33
Net Property & Equipment 26 26 24 22 20
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 109 110 111 110 110
Deposits & Other Assets 0 0 0 0 0
Total Assets 169 172 170 166 162
Liabilities & Shareholders Equity 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016
Notes Payable 1 0 3 0 0
Accounts Payable 2 2 3 3 3
Current Portion Long-Term Debt 0 1 0 3 3
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 5 7 7 6 6
Income Taxes Payable 1 1 0 0 1
Other Current Liabilities 5 5 9 10 9
Total Current Liabilities 15 17 22 22 23
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4 4 5 4 4
Convertible Debt 0 0 0 0 0
Long-Term Debt 49 54 50 50 43
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 68 74 77 76 74
Shareholders Equity 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 27 26 25 24 23
Capital Surplus 0 0 0 0 0
Retained Earnings 75 74 71 68 66
Other Equity -1 -2 -2 -1 -1
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 101 98 94 90 88
Total Liabilities & Shareholder's Equity 169 172 170 166 162
Total Common Equity 101 98 94 90 88
Shares Outstanding 3.70 3.70 3.60 3.60 3.60
Book Value Per Share 27.29 26.44 26.04 25.08 24.35